Answers are grounded in this paper and cite their sources.
New theranostic system enhances imaging and reduces oxidative stress in ischemic stroke, suggesting improved treatment.
Ischemic stroke (IS), with its high disability and mortality rates, remains a critical global health challenge, while current theranostic strategies fail to meet the demands of early diagnosis and timely intervention. Here, we report a breakthrough small‐molecule theranostic system ( ESL ) that integrates celastrol (Cel), a selective peroxynitrite (ONOO − )‐responsive trigger, and a hemicyanine‐based near‐infrared fluorophore. ESL undergoes a distinctive 1,4‐elimination reaction upon ONOO − activation, producing a 33‐fold fluorescence enhancement at 762 nm and enabling rapid visualization of ischemic lesions within 10 min. Therapeutically, ESL implements a dual‐mode strategy of instant scavenging and targeted delivery, simultaneously eliminating ONOO − ‐induced oxidative stress and releasing Cel to suppress neuroinflammation. This precise delivery markedly reduces systemic toxicity, achieving a superior safety profile compared with free Cel. Mechanistic studies further reveal that ESL inhibits the IL‐17/NF‐κB pathway, modulates microglial polarization, and suppresses pro‐inflammatory cytokines. Collectively, this work establishes an integrated “diagnosis–treatment–monitoring” paradigm for IS and provides a versatile platform for precision therapy of central nervous system disorders.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: